At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis
In Brief
A Phase 3 clinical trial evaluating Etanercept, Methotrexate, and 2 other interventions for Psoriatic Arthritis. Completed, enrolled 851 participants across 138 sites in 18 countries.
Detailed Summary
The purpose of this study is to learn more about the role of etanercept alone or in combination with methotrexate on disease activity in adults with psoriatic arthritis.
Study Details
Timeline
Interventions
Etanercept was administered by subcutaneous injection once a week
Methotrexate capsules taken orally once a week. Dosing was initiated at 10 mg weekly and titrated up to a final dose of 20 mg weekly over a 4-week period.
Placebo to etanercept was administered by subcutaneous injection once a week.
Placebo to methotrexate capsules taken orally once a week.